MAHLY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (20 Apr 2024 @ 02:42):

Stats
今日成交量	292.00
平均成交量	145.00
市值	3.20B
EPS	$28.08 ( 2023-09-30 )
Last Dividend	$0.185 ( 2021-09-28 )
Next Dividend	$0 ( N/A )
P/E	13.71
ATR14	$0 (0.00%)

MediPal Holdings 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

MediPal Holdings 财务报表

Annual	2023
营收:	$3 360.01B
毛利润:	$212.12B (6.31 %)
EPS:	$184.82

FY	2023
营收:	$3 360.01B
毛利润:	$212.12B (6.31 %)
EPS:	$184.82

FY	2022
营收:	$3 290.92B
毛利润:	$205.11B (6.23 %)
EPS:	$140.13

FY	2021
营收:	$3 211.17B
毛利润:	$214.26B (6.67 %)
EPS:	$113.96

Financial Reports:

No articles found.

MediPal Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MediPal Holdings Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.56 - low (18.41%) | Divividend Growth Potential Score: 1.062 - No dividend expected

Information

First Dividend	$0.191	2021-03-29
Last Dividend	$0.185	2021-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$0.376	--
Avg. Dividend % Per Year	0.00%	--
Score	1.71	--
Div. Sustainability Score	3.56
Div.Growth Potential Score	1.062
Div. Directional Score	2.31	--

Next Divdend (Est)
(2024-06-21)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

1.71

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TSCDY	Ex Dividend Knight	2023-05-11	Semi-Annually	0.00%
ITJTY	Ex Dividend Junior	2023-10-31	Annually	0.00%
BICEY	Ex Dividend Knight	2023-05-24	Annually	0.00%
RAFI	Ex Dividend Junior	2023-09-28	Quarterly	0.00%
EONGY	Ex Dividend Junior	2023-05-18	Annually	0.00%
VNRFY	Ex Dividend Junior	2023-05-30	Annually	0.00%
KSBI	Ex Dividend Knight	2023-07-28	Quarterly	0.00%
CCOEF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
SCYT	Ex Dividend Junior	2023-05-31	Annually	0.00%
FSNUY	Ex Dividend Junior	2023-05-18	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0106	1.500	9.79	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0199	1.200	9.34	10.00	[0 - 0.3]
returnOnEquityTTM	0.0646	1.500	-0.393	-0.590	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.198	0.800	9.01	7.21	[1 - 3]
quickRatioTTM	0.928	0.800	9.25	7.40	[0.8 - 2.5]
cashRatioTTM	0.194	1.500	-0.0355	-0.0533	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	2 643.15	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0647	1.000	-2.25	-2.25	[0.2 - 0.8]
operatingProfitMarginTTM	0.0151	1.000	-1.699	-1.699	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.872	0.800	0.854	0.683	[0.5 - 2]
Total Score				3.56

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.60	1.000	8.73	0	[1 - 100]
returnOnEquityTTM	0.0646	2.50	-0.253	-0.590	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0.00507	1.500	9.87	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00270	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				1.062

MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.